Willcare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
as on 17-11-2024
- Satisfied Charges ₹ 1.16 M
as on 17-11-2024
- Revenue 15.60%
(FY 2023)
- Profit 17.14%
(FY 2023)
- Ebitda 5.64%
(FY 2023)
- Net Worth 14.39%
(FY 2023)
- Total Assets -12.55%
(FY 2023)
About Willcare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M. The company has closed loans amounting to ₹1.16 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Jat, Prashant Singh, Prashant Srikanti, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232MP2011PTC025624
- Company No.
025624
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Willcare Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashank Bajpai  | Director | 15-Nov-2012 | Current |
| Prashant Srikanti | Director | 15-Nov-2012 | Current |
| Rajesh Jat | Director | 14-Apr-2023 | Current |
| Prashant Singh | Director | 15-Nov-2012 | Current |
| Ravi Sood | Director | 15-Nov-2012 | Current |
| Archana Patil | Director | 15-Nov-2012 | Current |
Financial Performance of Willcare Lifesciences.
Willcare Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.6% increase. The company also saw a substantial improvement in profitability, with a 17.14% increase in profit. The company's net worth Soared by an impressive increase of 14.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Willcare Lifesciences?
In 2023, Willcare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wilshire Pharmaceuticals Private LimitedActive 14 years 3 monthsRajesh Jat and Prashant Singh are mutual person
Wilburt Remedies Private LimitedActive 12 years 6 monthsRajesh Jat and Prashant Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Dec 2019 | ₹0.60 M | Open |
Axis Bank Limited Creation Date: 13 Sep 2016 | ₹0.66 M | Satisfied |
Axis Bank Limited Creation Date: 25 Mar 2015 | ₹0.50 M | Satisfied |
How Many Employees Work at Willcare Lifesciences?
Willcare Lifesciences has a workforce of 21 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Willcare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Willcare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
